Preview

Title

Advanced search

Necrotizing Pneumonia in Children as Viewed by a Telemedicine Consultants

https://doi.org/10.31550/1727-2378-2024-23-3-80-85

Abstract

Aim. To study problems that pediatricians face in the management of necrotizing pneumonia, and to show ways to its optimization.

Materials and methods. Necrotizing pneumonia is a serious disease that causes difficulties in the choice of antibiotics, indications for pleural interventions and termination of the therapy. Although mostly pneumococcal, pneumonias with purulent cavities and methapneumonic pleurisy (immunopathologic in its origin) are clinically resistance to antimicrobials, and it is taken by pediatricians as indications for changing antibiotics and pleural taps. Hence the importance of studying the prevalent tactics. We conducted analysis of 52 tele-requests for children with pulmonary consolidation and air-filled cavities. Its share among all “general pediatric” requests increased from 5% in 2021–2022 to 18% in 2023–2024. Of 52 patients 43 had also pleural effusions, 11 — pneumothorax. Pneumonia followed measles in 6 children, pertussis in 3, scarlet fever — in 1. All diagnostic and curative actions were compared to Clinical guidelines.

Results. In all instances conditions for hospital care (including intensive) were generally adequate, diagnostic activities were often redundant (nonrelevant analyses, multiple computer tomography instead of X-ray). Only 16 patients were started on cephtriiaxone and amoxicillin/clavulanate recommended by Clinical guides, the rest received reserve antibiotics. All patients received the 2nd course (combinations of the reserve antibiotics), 20 of them also the 3rd course. Steroids were given only to 3 patients. Of 43 children with pleurisy taps or drainage had 33, only 9 of them according to indications.

Conclusion. Pediatricians are not fully conversant with Clinical guides and it causes excessive administration of 2–3 courses of reserve antibiotics, unnecessary pleural interventions, infrequent use of steroid therapy that shortens the length of hospital stay.

About the Authors

V. K. Tatochenko
National Medical Research Center for Children’s Health
Russian Federation

2, build. 1 Lomonosovsky prospect, Moscow, 119991



M. J. Bakradze
National Medical Research Center for Children’s Health
Russian Federation

2, build. 1 Lomonosovsky prospect, Moscow, 119991



I. L. Chashchina
National Medical Research Center for Children’s Health
Russian Federation

2, build. 1 Lomonosovsky prospect, Moscow, 119991



References

1. Union of Pediatricians of Russia, Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy. Pneumonia (community acquired): clinical guidelines. Moscow; 2022. (in Russian).

2. Geppe N.A., Kozlova L.V., Kondurina E.G. et al. Community-acquired pneumonia in children: clinical guidelines. Moscow; 2020. (in Russian).

3. Baranov A.A., Kozlov R.S., Namazova-Baranova L.S. et al. Modern approaches at the management of children with community-acquired pneumonia. Pediatric pharmacology. 2023;20(1):17–41. (in Russian). DOI: 10.15690/pf.v20i1.2534

4. Tatochenko V.K., Bakradze M.D. Pediatrician for every day — 2022. Fever. Handbook of diagnosis and treatment. Moscow; 2022. (in Russian).

5. Russian Association of Pediatric Surgeons. Acute purulent destructive pneumonia in children: clinical recommendations. Moscow; 2018. (in Russian).

6. Tatochenko V.K., Bakradze M.D., Vershinin G.S., Babayan A.R. Telemedicine consultations in pediatrics — the structure and analysis. Doctor.Ru. 2023;22(3):7–14. (in Russian). DOI: 10.31550/1727-2378-2023-22-3-7-14

7. WHO. Providing hospital care for children: a guide to the treatment of the most common diseases in children. Geneva; 2013.

8. Ovsyannikov D.Yu., Pushko L.V., Gitinov Sh.A. et al. Obliterating bronchiolitis as an outcome of early measles pneumonia in a male infant. Diagnostic issues in pediatrics. 2013;5(2):41–46. (in Russian).

9. Kulichenko T.V., Baranov A.A., Namazova-Baranova L.S. et al. The influence of quality assurance and supportive supervision on the quality of medical care in children's hospitals of the municipal level of the Rostov region. Pediatric pharmacology. 2017;14(4):229–241. (in Russian). DOI: 10.15690/pf.v14i4.1754

10. Tatochenko V.K. Pain-sparing therapy methods of complicated community acquired pneumonia in children. Doctor.Ru. 2022;21(3):6-11. (in Russian). DOI: 10.31550/1727-2378-2022-21-3-6-11

11. Waight P.A., Andrews N.J., Ladhani S.N. et al. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect. Dis. 2015;15(5):535–543. DOI: 10.1016/S1473-3099(15)70044-7

12. Kaplan S.L., Barson W.J., Lin P.L. et al. Invasive pneumococcal disease in children’s hospitals; 2014–2017. Pediatrics. 2019;144(3):e20190567. DOI: 10.1542/peds.2019-0567

13. Tan T.Q. What's new in pediatric vaccines. Contemporary PEDS J. 2023;40(9):28–29.

14. Tagarro A., Otheo E., Baquero-Artigao F. et al. Dexamethasone for parapneumonic pleural effusion: a randomized, doubleblind, clinical trial. J. Pediatr. 2017;185:117–123. DOI: 10.1016/j.jpeds.2017.02.043


Review

For citations:


Tatochenko V.K., Bakradze M.J., Chashchina I.L. Necrotizing Pneumonia in Children as Viewed by a Telemedicine Consultants. Title. 2024;23(3):80-85. (In Russ.) https://doi.org/10.31550/1727-2378-2024-23-3-80-85

Views: 17


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1727-2378 (Print)
ISSN 2713-2994 (Online)